HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terence S Herman Selected Research

Terence S Herman Research Topics

Disease

27Neoplasms (Cancer)
10/2022 - 02/2002
11Neuroblastoma
01/2021 - 04/2008
5Pancreatic Neoplasms (Pancreatic Cancer)
10/2019 - 10/2011
5Neoplasm Metastasis (Metastasis)
01/2017 - 01/2013
4Breast Neoplasms (Breast Cancer)
04/2017 - 04/2009
2Carcinogenesis
12/2019 - 01/2019
2Disease Progression
12/2019 - 01/2019
2Residual Neoplasm
10/2019 - 09/2015
2Retinal Degeneration
10/2017 - 11/2015
2Lung Neoplasms (Lung Cancer)
07/2010 - 01/2010
1Melanoma (Melanoma, Malignant)
10/2022
1Mucoepidermoid Carcinoma
10/2019
1Spontaneous Remission
01/2019
1Triple Negative Breast Neoplasms
04/2017
1Wounds and Injuries (Trauma)
08/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2013
1Cognitive Dysfunction
03/2011
1Microvascular Rarefaction
03/2011
1Brain Neoplasms (Brain Tumor)
03/2011
1Hypoxia (Hypoxemia)
03/2011
1Hyperthermia
04/2009
1Carcinoma (Carcinomatosis)
10/2006
1Keloid
04/2006
1Cicatrix (Scar)
04/2006
1Mitochondrial Diseases (Mitochondrial Disease)
11/2004
1Prostatic Neoplasms (Prostate Cancer)
11/2004
1Hepatocellular Carcinoma (Hepatoma)
11/2004
1Merkel Cell Carcinoma
10/2004
1Genomic Instability
11/2003
1Pheochromocytoma
02/2002
1Acoustic Neuroma (Acoustic Neurinoma)
01/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
10/2017 - 10/2011
4PolyphenolsIBA
10/2019 - 01/2013
3MicroRNAs (MicroRNA)IBA
01/2019 - 07/2015
3DNA (Deoxyribonucleic Acid)IBA
08/2013 - 04/2009
3CurcuminIBA
10/2011 - 04/2008
2AntioxidantsIBA
10/2019 - 05/2002
2Cadherins (E-Cadherin)IBA
09/2015 - 08/2013
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2013 - 03/2011
2irofulvenIBA
11/2004 - 11/2004
2MelatoninIBA
07/2004 - 05/2002
1Iodine-125IBA
10/2022
1Surface Antigens (Surface Antigen)IBA
01/2021
1Oncogene Proteins (Oncogene Protein)IBA
10/2019
1Protons (Proton)IBA
10/2019
1ParaffinIBA
01/2019
1Formaldehyde (Formol)FDA Link
01/2019
1Guanylate Cyclase (Guanylyl Cyclase)IBA
10/2017
1AntibodiesIBA
10/2017
1EpitopesIBA
10/2017
1Cytotoxins (Cytolysins)IBA
04/2017
1Small Interfering RNA (siRNA)IBA
04/2017
1Biomarkers (Surrogate Marker)IBA
04/2016
1CateninsIBA
07/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2015
1Type I Tumor Necrosis Factor ReceptorsIBA
07/2015
1Tissue Inhibitor of Metalloproteinase-2IBA
08/2013
1PhytochemicalsIBA
03/2013
1Tyrosine Kinase InhibitorsIBA
03/2013
1EKB 569IBA
03/2013
1Messenger RNA (mRNA)IBA
03/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2011
1Oxygen (Dioxygen)IBA
03/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2009
1NF-KappaB Inhibitor alphaIBA
04/2009
1Radiation-Sensitizing AgentsIBA
04/2008
1CaspasesIBA
11/2004
1Free RadicalsIBA
07/2004
1Hydroxyl RadicalIBA
07/2004
1bizelesinIBA
11/2003
1Cisplatin (Platino)FDA LinkGeneric
02/2002

Therapy/Procedure

17Radiotherapy
10/2019 - 02/2002
10Therapeutics
12/2019 - 05/2002
3Drug Therapy (Chemotherapy)
04/2017 - 10/2004
2Brachytherapy
10/2022 - 04/2020
1Aftercare (After-Treatment)
08/2013
1Molecular Targeted Therapy
05/2009
1Induced Hyperthermia (Thermotherapy)
04/2009
1Image-Guided Radiotherapy
11/2004
1Patient Positioning
07/2004
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2002